Ariad Pharmaceuticals Inc. (ARIA) was a big mover last session as its shares surged over 35% on the day. The surge came on solid volume too with far more shares changing hands than in a normal session. This is in conformity with the uptrend for the healthcare company since Oct 31, as the stock is now up roughly 72%.
In the last 60-day frame, Ariad Pharmaceuticals witnessed 11 positive estimate revisions and the Zacks Consensus Estimate also moved higher. So make sure to stay glued to this stock going forward to see if Friday’s sharp climb can translate into more strength down the road.
Ariad Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.
However, some better-ranked medical stocks worth considering include Jazz Pharmaceuticals plc (JAZZ), Lannett Company, Inc. (LCI) and Sucampo Pharmaceuticals, Inc. (SCMP). All three stocks carry a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment